Cargando…

The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis

The Pak4 serine/threonine kinase is highly expressed in many cancer cell lines and human tumors. While several studies have addressed the role for Pak4 in transformation of fibroblasts, most human cancers are epithelial in origin. Epithelial cancers are associated not only with changes in cell growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yingying, Chen, Ning, Cui, Xiaoxing, Zheng, Xi, Deng, Li, Price, Sandy, Karantza, Vassiliki, Minden, Audrey
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974003/
https://www.ncbi.nlm.nih.gov/pubmed/20697354
http://dx.doi.org/10.1038/onc.2010.329
_version_ 1782190859065753600
author Liu, Yingying
Chen, Ning
Cui, Xiaoxing
Zheng, Xi
Deng, Li
Price, Sandy
Karantza, Vassiliki
Minden, Audrey
author_facet Liu, Yingying
Chen, Ning
Cui, Xiaoxing
Zheng, Xi
Deng, Li
Price, Sandy
Karantza, Vassiliki
Minden, Audrey
author_sort Liu, Yingying
collection PubMed
description The Pak4 serine/threonine kinase is highly expressed in many cancer cell lines and human tumors. While several studies have addressed the role for Pak4 in transformation of fibroblasts, most human cancers are epithelial in origin. Epithelial cancers are associated not only with changes in cell growth, but also with changes in the cellular organization within the three dimensional (3D) architecture of the affected tissues. Here we used immortalized mouse mammary epithelial cells (iMMECs) as a model system to study the role for Pak4 in mammary tumorigenesis. iMMECs are an excellent model system for studying breast cancer they can grow in 3D-epithelial cell culture, where they form acinar structures that recapitulate in vivo mammary morphogenesis. While Pak4 is expressed at low levels in wild type iMMECs, it is overexpressed in response to oncogenes, such as oncogenic Ras and Her2/neu. Here we found that overexpression of Pak4 in iMMECs leads to changes in 3D acinar architecture that are consistent with oncogenic transformation. These include decreased central acinar cell death, abrogation of lumen formation, cell polarity alterations, and deregulation of acinar size and cell number. Furthermore, iMMECs overexpressing Pak4 form tumors when implanted into the fat pads of athymic mice. Our results suggest that overexpression of Pak4 triggers events that are important for the transformation of mammary epithelial cells. This is likely to be due to the ability of Pak4 to inhibit apoptosis and promote cell survival, and thus subsequent uncontrolled proliferation, and to its ability to deregulate cell shape and polarity.
format Text
id pubmed-2974003
institution National Center for Biotechnology Information
language English
publishDate 2010
record_format MEDLINE/PubMed
spelling pubmed-29740032011-05-04 The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis Liu, Yingying Chen, Ning Cui, Xiaoxing Zheng, Xi Deng, Li Price, Sandy Karantza, Vassiliki Minden, Audrey Oncogene Article The Pak4 serine/threonine kinase is highly expressed in many cancer cell lines and human tumors. While several studies have addressed the role for Pak4 in transformation of fibroblasts, most human cancers are epithelial in origin. Epithelial cancers are associated not only with changes in cell growth, but also with changes in the cellular organization within the three dimensional (3D) architecture of the affected tissues. Here we used immortalized mouse mammary epithelial cells (iMMECs) as a model system to study the role for Pak4 in mammary tumorigenesis. iMMECs are an excellent model system for studying breast cancer they can grow in 3D-epithelial cell culture, where they form acinar structures that recapitulate in vivo mammary morphogenesis. While Pak4 is expressed at low levels in wild type iMMECs, it is overexpressed in response to oncogenes, such as oncogenic Ras and Her2/neu. Here we found that overexpression of Pak4 in iMMECs leads to changes in 3D acinar architecture that are consistent with oncogenic transformation. These include decreased central acinar cell death, abrogation of lumen formation, cell polarity alterations, and deregulation of acinar size and cell number. Furthermore, iMMECs overexpressing Pak4 form tumors when implanted into the fat pads of athymic mice. Our results suggest that overexpression of Pak4 triggers events that are important for the transformation of mammary epithelial cells. This is likely to be due to the ability of Pak4 to inhibit apoptosis and promote cell survival, and thus subsequent uncontrolled proliferation, and to its ability to deregulate cell shape and polarity. 2010-08-09 2010-11-04 /pmc/articles/PMC2974003/ /pubmed/20697354 http://dx.doi.org/10.1038/onc.2010.329 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Liu, Yingying
Chen, Ning
Cui, Xiaoxing
Zheng, Xi
Deng, Li
Price, Sandy
Karantza, Vassiliki
Minden, Audrey
The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
title The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
title_full The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
title_fullStr The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
title_full_unstemmed The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
title_short The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
title_sort protein kinase pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974003/
https://www.ncbi.nlm.nih.gov/pubmed/20697354
http://dx.doi.org/10.1038/onc.2010.329
work_keys_str_mv AT liuyingying theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT chenning theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT cuixiaoxing theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT zhengxi theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT dengli theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT pricesandy theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT karantzavassiliki theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT mindenaudrey theproteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT liuyingying proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT chenning proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT cuixiaoxing proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT zhengxi proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT dengli proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT pricesandy proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT karantzavassiliki proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis
AT mindenaudrey proteinkinasepak4disruptsmammaryacinararchitectureandpromotesmammarytumorigenesis